Patent 7786308 was granted and assigned to Vertex Pharmaceuticals on August, 2010 by the United States Patent and Trademark Office.
The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.